Category: Alnylam
-
Alnylam, Lilly, AstraZeneca among best performing pharmas, biotechs in Q2
•
Al-Naylam Pharmaceuticals CompanyNasdaq: ALLNEY) The best-performing large-cap company ($30+ billion) was in the pharmaceutical or biotechnology space in the second quarter, Yield ~58.5% In the period. The biotech company’s strong performance was helped significantly in late June when it announced strong pivotal trial results for vutrisiran, a treatment for ATTR…